Literature DB >> 15115762

Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes.

Dominique Helmlinger1, Sara Hardy, Souphatta Sasorith, Fabrice Klein, Flavie Robert, Chantal Weber, Laurent Miguet, Noëlle Potier, Alain Van-Dorsselaer, Jean-Marie Wurtz, Jean-Louis Mandel, Làszlò Tora, Didier Devys.   

Abstract

Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder caused by a CAG repeat expansion in the SCA7 gene leading to elongation of a polyglutamine tract in ataxin-7, a protein of unknown function. A putative ataxin-7 yeast orthologue (SGF73) has been identified recently as a new component of the SAGA (Spt/Ada/Gcn5 acetylase) multisubunit complex, a coactivator required for transcription of a subset of RNA polymerase II-dependent genes. We show here that ataxin-7 is an integral component of the mammalian SAGA-like complexes, the TATA-binding protein-free TAF-containing complex (TFTC) and the SPT3/TAF9/GCN5 acetyltransferase complex (STAGA). In agreement, immunoprecipitation of ataxin-7 retained a histone acetyltransferase activity, characteristic for TFTC-like complexes. We further identified a minimal domain in ataxin-7 that is required for interaction with TFTC/STAGA subunits and is conserved highly through evolution, allowing the identification of a SCA7 gene family. We showed that this domain contains a conserved Cys(3)His motif that binds zinc, forming a new zinc-binding domain. Finally, polyglutamine expansion in ataxin-7 did not affect its incorporation into TFTC/STAGA complexes purified from SCA7 patient cells. We demonstrate here that ataxin-7 is the human orthologue of the yeast SAGA SGF73 subunit and is a bona fide subunit of the human TFTC-like transcriptional complexes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115762     DOI: 10.1093/hmg/ddh139

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  93 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

Review 2.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 3.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

4.  Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model.

Authors:  Yi Chun Chen; Jennifer R Gatchel; Rebecca W Lewis; Chai-An Mao; Patrick A Grant; Huda Y Zoghbi; Sharon Y R Dent
Journal:  Hum Mol Genet       Date:  2011-10-14       Impact factor: 6.150

5.  Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.

Authors:  Henrietta Szutorisz; Claudia Canzonetta; Andrew Georgiou; Cheok-Man Chow; László Tora; Niall Dillon
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  SAGA complex mediates the transcriptional up-regulation of antiviral RNA silencing.

Authors:  Ida Bagus Andika; Atif Jamal; Hideki Kondo; Nobuhiro Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

Review 7.  The SAGA continues: expanding the cellular role of a transcriptional co-activator complex.

Authors:  S P Baker; P A Grant
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

8.  SAGA-mediated H2B deubiquitination controls the development of neuronal connectivity in the Drosophila visual system.

Authors:  Vikki M Weake; Kenneth K Lee; Sebastián Guelman; Chia-Hui Lin; Christopher Seidel; Susan M Abmayr; Jerry L Workman
Journal:  EMBO J       Date:  2008-01-10       Impact factor: 11.598

9.  The double-histone-acetyltransferase complex ATAC is essential for mammalian development.

Authors:  Sebastián Guelman; Kenji Kozuka; Yifan Mao; Victoria Pham; Mark J Solloway; John Wang; Jiansheng Wu; Jennie R Lill; Jiping Zha
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

10.  Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.

Authors:  Pavitra S Ramachandran; Ryan L Boudreau; Kellie A Schaefer; Albert R La Spada; Beverly L Davidson
Journal:  Mol Ther       Date:  2014-06-16       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.